Tag: Boston Scientific

Next-generation Watchman LAAC device gains US FDA approval

Boston Scientific has received US Food and Drug Administration (FDA) approval for the Watchman F...

Boston Scientific reveals CE mark for Acurate neo 2 in Q1 financial results report

Boston Scientific, according to a press release announcing the company’s Q1 2020 financial resul...

ACURATE neo helps facilitate early discharge following TAVI procedures

NOTE: This video is ONLY available to watch in selected countries and geographies Rajesh ...

Selecting the right valve for the patient is key for a successful TAVI program

NOTE: This video is ONLY available to watch in selected countries and geographies

Boston Scientific announces schedule of presentations at TCT 2019

Boston Scientific has announced the key data that will be presented at the Transcatheter Cardiov...

Novel repositionable TAVI valve has acceptable early clinical outcomes

A new study indicates that the Meridian transcatheter aortic valve implantation (TAVI) valve (HL...

New trial to compare Watchman FLX to direct oral anticoagulants

The OPTION trial is to compare the compare safety and effectiveness of the next-generation Watch...

Boston Scientific initiates trial comparing left atrial appendage closure to direct oral anticoagulants for stroke risk reduction post-AFib ablation

According to a press release, Boston Scientific has initiated the OPTION trial to compare safety...

Lotus Edge becomes third TAVI device on US market

Boston Scientific has received US FDA approval for its Lotus Edge transcatheter aortic valve imp...

CE mark for Watchman FLX left atrial appendage closure device

Boston Scientific announced it has received CE mark and initiated a limited market release of the ne...

Boston Scientific, Edwards Lifesciences agree to global litigation settlement

Boston Scientific and Edwards Lifesciences today announced that the companies have reached an agreem...

Boston Scientific exercises option to acquire Millipede

Boston Scientific has exercised its option to acquire the remaining shares of Millipede, upon it...

US District Court for the District of Delaware rules that Sapien 3 infringes a Boston Scientific patent

A jury in the US District Court for the District of Delaware determined that the Boston Scientif...

ADVERTORIAL: Unique design and features of the ACURATE neo (TM) enable safe and efficient procedures

This content is only for readers outside of the US as it discusses a device that is not FDA appr...

PCR LV 2018: Favourable outcomes for next-generation Acurate neo2 TAVI system

A new study evaluating the safety and performance of the Acurate neo2 (Boston Scientific) transc...

Boston Scientific to buy cerebral protection system company

Boston Scientific has signed an agreement to acquire Claret Medical, which developed and commerciali...

EuroPCR 2018: Boston Scientific outlines its key presentations

Boston Scientific Corporation has revealed its schedule of key presentations—including two late-...

Boston Scientific successfully opposes Edwards Lifesciences Corporation’s European patent EP 2,399,550 (550)

According to a press release, Boston Scientific has, along with several other opponents, success...

UK Court of Appeal dismisses Edwards Lifesciences’ appeal against Sapien 3 infringement ruling

Acurate neo Boston Scientific has announced the UK Court of Appeal  dismissed Edwards Lifesc...

Short-term DAPT is feasible for patients undergoing percutaneous LAA closure

Felix Weise (Cardioangiologisches Centrum Bethanien, Frankfurt, Germany) and others report in Eu...

Boston Scientific enters into an acquisition option agreement with Millipede

Boston Scientific has closed an investment and entered into an acquisition option agreement with...

Boston Scientific pushes back plans for commercialisation of Lotus Edge TAVI device

Boston Scientific has announced a delay to the previously communicated timelines for the commerc...

TCT 2017: Vivek Reddy on the final outcomes of PREVAIL and PROTECT-AF

Boston Scientific has announced the final five-year outcomes data from the PREVAIL study during ...

TCT 2017: No role for bare metal stents to reduce duration of dual antiplatelet therapy in older patients

Olivier Varenne (Hôpital Cochin, Assistance Publique—Hôpitaux De Paris, Paris, France) reported ...

TCT 2017: Boston Scientific reveals presentations at conference

Boston Scientific has announced key data will be presented at next week’s Transcatheter Cardiova...

PCR LV 2017: Refining implantation technique and device iterations may improve pacemaker rate seen with Lotus

New data from REPRISE III indicate that keeping the bottom of the frame at annular level while i...

ESC 2017: Best-practice PCI outperforms conventional PCI in patients with de novo three-vessel disease

The SYNTAX II study has found that percutaneous coronary intervention (PCI) using state-of-the-a...

EuroPCR 2017: Lotus TAVI device has superior efficacy to CoreValve at one year

Data from the REPRISE III trial indicate that the Lotus transcatheter aortic valve implantation (TAV...

SCAI 2017: New data from PLATINUM Diversity study provide further insight into under-served populations

New analyses from the PLATINUM Diversity study underscore the need for greater understanding of ...

Boston Scientific closes Symetis acquisition

Boston Scientific Corporation has announced the close of its acquisition of Symetis SA, a privat...

ADVERT: SYNERGY™

Everolimus-Eluting Platinum Chromium Coronary Stent System Drug Eluting stent technology with...

UK Patents Court makes initial decision on Edwards Sapien 3 and Boston Scientific’s patents

The Patents Court in the UK has determined that one of Boston Scientific’s patents related to ou...

Corindus Vascular Robotics announces private placement for US$45 million

Corindus Vascular Robotics has entered into a Securities Purchase Agreement pursuant to which it...

Locking mechanism problems prompt Boston Scientific to recall all ranges of its Louts TAVI device

According to Reuters, Boston Scientific is recalling all ranges of its transcatheter aortic valv...

Boston Scientific closes acquisition of certain Neovasc assets

Boston Scientific Corporation has closed its acquisition of certain manufacturing assets and cap...

Boston Scientific to acquire Neovasc biological tissue capabilities

Boston Scientific has agreed to acquire certain manufacturing assets and capabilities of the Neo...

TCT 2016: Women and minorities have a significantly higher risk of death after PCI than white men

Data from the PLATINUM DIVERSITY trial, which was presented at the 2016 Transcatheter Cardiovasc...

TCT 2016: Boston Scientific announces scheduled presentations

Boston Scientific has announced key data that will be presented at the 2016 Transcatheter Cardio...

Ian Meredith to become global chief medical officer of Boston Scientific

Ian Meredith, currently professor of Medicine and Cardiology for Monash University, Director of ...

Two-year MAJESTIC data show sustained positive results for Eluvia drug-eluting stent

The MAJESTIC trial set out to evaluate the performance of the Eluvia paclitaxel-eluting vascular ste...

PCRLV 2016: Next-generation of Lotus TAVI receives CE mark

Coinciding with PCR London Valves (18-20 September, London, UK), Boston Scientific has announced...

Boston Scientific issues urgent recall of Lotus systems manufactured prior to March 2016.

Boston Scientific has sent a letter to its customers notifying them that it is implementing a “v...